GB9419013D0 - Fatty acid medicament - Google Patents

Fatty acid medicament

Info

Publication number
GB9419013D0
GB9419013D0 GB9419013A GB9419013A GB9419013D0 GB 9419013 D0 GB9419013 D0 GB 9419013D0 GB 9419013 A GB9419013 A GB 9419013A GB 9419013 A GB9419013 A GB 9419013A GB 9419013 D0 GB9419013 D0 GB 9419013D0
Authority
GB
United Kingdom
Prior art keywords
fatty acid
acid medicament
medicament
fatty
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9419013A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Priority to GB9419013A priority Critical patent/GB9419013D0/en
Publication of GB9419013D0 publication Critical patent/GB9419013D0/en
Priority to NZ280017A priority patent/NZ280017A/en
Priority to EP95306505A priority patent/EP0707850A1/en
Priority to ZA957903A priority patent/ZA957903B/en
Priority to CA002158591A priority patent/CA2158591A1/en
Priority to JP7241840A priority patent/JPH08198753A/en
Priority to AU31765/95A priority patent/AU3176595A/en
Pending legal-status Critical Current

Links

GB9419013A 1994-09-21 1994-09-21 Fatty acid medicament Pending GB9419013D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB9419013A GB9419013D0 (en) 1994-09-21 1994-09-21 Fatty acid medicament
NZ280017A NZ280017A (en) 1994-09-21 1995-09-14 Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
EP95306505A EP0707850A1 (en) 1994-09-21 1995-09-14 Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
ZA957903A ZA957903B (en) 1994-09-21 1995-09-19 Fatty acid treatment
CA002158591A CA2158591A1 (en) 1994-09-21 1995-09-19 Fatty acid treatment
JP7241840A JPH08198753A (en) 1994-09-21 1995-09-20 Medical treatment with fatty acid
AU31765/95A AU3176595A (en) 1994-09-21 1995-09-20 Fatty acid treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9419013A GB9419013D0 (en) 1994-09-21 1994-09-21 Fatty acid medicament

Publications (1)

Publication Number Publication Date
GB9419013D0 true GB9419013D0 (en) 1994-11-09

Family

ID=10761676

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9419013A Pending GB9419013D0 (en) 1994-09-21 1994-09-21 Fatty acid medicament

Country Status (2)

Country Link
GB (1) GB9419013D0 (en)
ZA (1) ZA957903B (en)

Also Published As

Publication number Publication date
ZA957903B (en) 1996-05-27

Similar Documents

Publication Publication Date Title
GB9403857D0 (en) Fatty acid derivatives
GB9618420D0 (en) Fatty acid treatment
EP0730447A4 (en) Fatty acid delivery system
GB9408117D0 (en) Pharmaceutical formulations
GB9404248D0 (en) Pharmaceutical formulations
GB9508023D0 (en) Fatty acid derivatives
AU659456B2 (en) Fatty acid treatment
EP0801644A4 (en) Polyarylcarbamoylaza -and- carbamoylalkanedioic acids
ZA95225B (en) alpha-pyrimidinyl acrylic acid derivatives
HU9500728D0 (en) 5-vinyl- and 5-ethinyl-quinolon- and -naphtiridone-carboxylig acids
EP0774965A4 (en) Phenoxyphenylacetic acid derivatives
GB9621373D0 (en) Fatty acid treatment
AU3176595A (en) Fatty acid treatment
ZA9510888B (en) 3-aryl-tetronic acid derivatives
HU9700148D0 (en) Trifluoromethylquinolinecarboxylic acid derivative
GB9419013D0 (en) Fatty acid medicament
GB9418550D0 (en) Drug formulation
SG28202A1 (en) Fatty acid derivatives
GB9515185D0 (en) Fatty acid treatment
KR0137670B1 (en) 5-METHYL-5-0-(Ñß-D-GLUCOPYRANOSYL)-D-ERYTHROASCORBIC ACID
GB9407641D0 (en) Essential fatty acid supplements
GB9621294D0 (en) Fatty acid treatment
ZA95301B (en) Furazancarboxylic acid derivatives
KR0137624B1 (en) 5-METHYL-5-0(Ñß-D-ZYLOPYRANOSYL)-D-ERYTHROASCORBIC ACID
GB9700383D0 (en) Fatty acid treatent